Seasonal Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Seasonal Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-29Clinical Trial Update: An Exploratory Study of PQ Grass 27600 SU [Phase 2, Phase 3]
An exploratory study of PQ Grass 27600 SU completed phases 2 and 3 for seasonal allergic rhinitis, with results posted in 2026.
-
CLINICAL_TRIALS trial_result · 2026-04-29Clinical Trial Results: An Exploratory Study of PQ Grass 27600 SU [Phase 2, Phase 3]
Results from an exploratory phase 2/3 trial of PQ Grass 27600 SU in seasonal allergic rhinitis have been completed with results posted.
-
EMA approval · 2026-04-07EMA Authorised: Aerinaze (desloratadine;pseudophedrine sulfate) — Organon N.V.
EMA authorized Aerinaze, a fixed-dose combination of desloratadine and pseudoephedrine sulfate, for allergic rhinitis with seasonal symptoms…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis [Phase 2]
A Phase 2 clinical trial is investigating TQH2722 injection with background therapy for seasonal allergic rhinitis and is currently recruiti…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Special Drug Use Observational Study of Xolair in Patients With Severe to Most Severe Seasonal Allergic Rhinitis Aged ≥ 12 Years and < 18 Years Whose Symptoms Were Inadequately Controlled Despite to Conventional Therapies
This clinical trial update reports a special drug use observational study of omalizumab (Xolair) in adolescents aged 12 to 17 with seasonal …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: A Prospective Study of Stapokibart Injection in Patients With Seasonal Allergic Rhinitis (SAR)
A prospective study evaluating Stapokibart Injection for seasonal allergic rhinitis, with the trial currently not yet recruiting.
-
EMA approval · 2026-03-02EMA Authorised: Azomyr (desloratadine) — Organon N.V.
The European Medicines Agency authorised Azomyr, a desloratadine-containing medicine by Organon N.V., for allergic rhinitis (seasonal and pe…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Seasonal Allergic Rhinitis [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of the investigational drug AK139 for seasonal allergic rhinitis; the study is c…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Clinical Trial of TQC2938 Injection in Patients With Seasonal Allergic Rhinitis [Phase 2]
Phase 2 clinical trial of TQC2938 injection for seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Efficacy and Safety of LP-003 Injection in Patients With Moderate to Severe Seasonal Allergic Rhinitis [Phase 3]
Phase 3 clinical trial update evaluating the efficacy and safety of LP-003 injection in patients with moderate to severe seasonal allergic r…
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: Efficacy and Safety of LP-003 in Moderate-to-severe Seasonal Allergic Rhinitis Adult [Phase 2]
Phase 2 trial update assessing the efficacy and safety of LP-003 in adults with moderate-to-severe seasonal allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients [Phase 1]
Phase 1 clinical pharmacology study of MT-2990 in seasonal allergic rhinitis has been completed, providing early pharmacokinetic and safety …
-
CLINICAL_TRIALS research · 2025-10-22Clinical Trial Update: A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With Seasonal Allergic Rhinitis Under Allergen Exposure [Phase 2]
A Phase 2 trial to determine the optimal dose and dosing frequency of ALDP001 nasal spray for adults with seasonal allergic rhinitis is curr…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Phleum Pratense and Dactylis Glomerata Allergen Extracts Standardization [NA]
A completed clinical trial from Inmunotek S.L. focusing on standardizing Phleum pratense and Dactylis glomerata allergen extracts for pollen…
-
CLINICAL_TRIALS other · 2025-09-30Clinical Trial Update: A Study of GR1802 Injection in Patients With Seasonal Allergic Rhinitis. [Phase 3]
Clinical trial update indicating a Phase 3 study of GR1802 injections for seasonal allergic rhinitis is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Study of CM310 in Patients With Uncontrolled Seasonal Allergic Rhinitis [Phase 2]
A Phase 2 clinical trial evaluating CM310 for uncontrolled seasonal allergic rhinitis is currently recruiting at Beijing Tongren Hospital.
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis [Phase 3]
Phase 3 clinical trial evaluating an IL-4Rα monoclonal antibody for seasonal allergic rhinitis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study [NA]
The CARISTA study at the University of Melbourne is currently recruiting participants to develop a risk assessment tool for thunderstorm-rel…
-
CLINICAL_TRIALS trial_result · 2025-09-03Clinical Trial Update: A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis [Phase 2]
This document describes a Phase 2 clinical trial evaluating the efficacy, safety, pharmacokinetics and pharmacodynamics of SHR-1819 injectio…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: A Phase III Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis [Phase 3]
This trial entry outlines a Phase III study to evaluate the efficacy and safety of PG-011 Nasal Spray in adults with moderate to severe seas…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Clinical Trial of TQH2722 Injection in Patients With Seasonal Allergic Rhinitis [Phase 2]
Phase 2 clinical trial of TQH2722 Injection for seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Acupuncture at the Sphenopalatine Ganglion in the Treatment of Moderate-to-severe Seasonal Allergic Rhinitis [NA]
A ClinicalTrials.gov entry describes a recruiting study evaluating acupuncture at the sphenopalatine ganglion for moderate-to-severe seasona…
-
FDA approval · 2025-07-01FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for montelukast sodium from Ajanta Pharma USA Inc., updating the approved ANDA product via a supplem…
-
FDA approval · 2025-07-01FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
The FDA approved a supplemental application for Montelukast Sodium from Ajanta Pharma USA Inc., under an ANDA.
-
FDA approval · 2025-07-01FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for Montelukast Sodium (generic montelukast) submitted by Ajanta Pharma USA Inc. under ANDA203328.